Newsummit Biopharma Holdings IPO Research Information

Newsummit Biopharma Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Newsummit Biopharma Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Newsummit Biopharma Holdings	NSB - NYSE	TBD	$0.00	$0.00	TBD
Underwriter(s): Oppenheimer & Co., Cowen & Co.
Co-Manager(s):
Industry:
Filing(s): Filed 2012-02-24

About Newsummit Biopharma Holdings (adapted from Newsummit Biopharma Holdings prospectus):
They are a leading China-based new drug development process solutions provider.

This description is adapted from Newsummit Bio prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Newsummit Bio "NSB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.